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Abstract 
The aim of this research was to develop chitosan/gelatin/keratin composite containing hydrocortisone sodium 
succinate as a buccal mucoadhesive patch to treat desquamative gingivitis, which was fabricated through an 
environmental friendly process. Mucoadhesive films increase the advantage of higher efficiency and drug 
localization in the affected region. In this research, mucoadhesive films, for the release of hydrocortisone 
sodium succinate, were prepared using different ratios of chitosan, gelatin and keratin. In the first step, chitosan 
and gelatin proportions were optimized after evaluating the mechanical properties, swelling capacity, water 
uptake, stability, and biodegradation of the films. Then, keratin was added at different percentages to the 
optimum composite of chitosan and gelatin together with the drug. The results of surface pH showed that none 
of the samples were harmful to the buccal cavity. FTIR analysis confirmed the influence of keratin on the 
structure of the composite. The presence of a higher amount of keratin in the composite films resulted in high 
mechanical, mucoadhesive properties and stability, low water uptake and biodegradation in phosphate buffer 
saline (pH = 7.4) containing 104 U/ml lysozyme. The release profile of the films ascertained that keratin is a rate 
controller in the release of the hydrocortisone sodium succinate. Finally, chitosan/gelatin/keratin composite 
containing hydrocortisone sodium succinate can be employed in dental applications. 
Keywords: Chitosan, gelatin, keratin, hydrocortisone sodium succinate, composite, drug release 
Introduction 
Periodontal disease, such as lichen planus, is a general term that describes different pathological conditions that 
cause weakening, inflammation, and erosion of alveolar bone and gingival tissue. Desquamative gingivitis is an 
oral manifestation of lichen planus where the appearance of gingiva becomes red, glazed and swollen. Most 
patients that are suffering from desquamative gingivitis can be treated by topical corticosteroids, such as 
immunosuppressive drugs [[ 1]]. Hydrocortisone sodium succinate is a water soluble derivative of 
hydrocortisone, a synthetic corticosteroid with anti-inflammatory, antivirus and anti-coma properties, and is 
administered in case of desquamative gingivitis [[ 3]]. Local administration is preferred because not only a high 
activity of steroids can be achieved in situ, but also, systemic side effects can be minimized or avoided [[ 5]]. 
Interaction of such systems with mucus-coated surfaces or mucous membrane enhances the residence time of 
the dosage form at the site of absorption. Topical buccal therapy is one of the most preferred strategies 
amongst mucoadhesive delivery systems, as it has been reported to be useful in controlling ulcerative and 
inflammatory mucosal diseases with steroid anti-inflammatory drugs. Also, the delivery of drugs into the oral 
cavity can prevent the first-pass effect. This can be an operative method to deliver drugs that are expected to be 
effective in the oral cavity [[ 6]]. Various mucoadhesive systems in the form of microparticles/discs [[ 8]], tablets 
[[ 5], [ 9]], paste [[10]] and films [[11]] containing different drugs such as bethamethasone disodium phosphate 
[[ 8]], mycophenolate mofetil [[12]], hydrocortisone acetate [[ 5]], clobetasol 17 propionate [[ 9]], curcumin 
[[10]], triamcinolone acetonide, and Licorice [[11]]. Amongst mucoadhesive systems, films are preferred due to 
their flexibility, low thickness and comfort [[13]]. Also, compared to oral gels, such films can remain in the lesion 
for a longer period of time [[14]]. Moreover, they can deliver a more accurate concentration of the drug to the 
target region [[16]]. An ideal mucoadhesive film should not induce sensitivity, dryness, or bad taste in the 
mouth, and it should provide comfort to the patient along with enough flexibility, elasticity, and resistance to 
fracture due to actions that induce mechanical compression, such as mastication [[17]]. Furthermore, it should 
have acceptable mucoadhesive properties with a limited swelling ratio to remain in the mouth properly for a 
specific period of time [[15], [18]]. 
Various formulations have been employed as mucoadhesive delivery systems including hydroxypropylmethyl 
cellulose, carboxyvinyl polymer, and polycarbophyl [[ 5]], poly(sodium methacrylate, methylmethacrylate), with 
hydroxypropylmethylcellulose and MgCl2 [[ 9]], pectin, gelatin and sodium carboxymethyl cellulose [[10]], 
polyelectrolyte complexes of chitosan and gelatin [[19]] amongst which the latter has attracted considerable 
attention nowadays [[20]] due to mucoadhesiveness of chitosan that is related to its cationic polyelectrolyte 
structure [[27]], non-toxicity, stability, biocompatibility, and sterilizability of this natural polymer [[28]] along 
with biocompatibility, plasticity, adhesiveness and desirable cell adhesion of gelatin [[29]] making such 
formulation an appropriate candidate for the fabrication of mucoadhesive buccal films with reliable 
characteristics [[19]]. In order to control the biodegradation, keratin could be added to the biodegradable 
formulations used for drug delivery systems [[30]]. Keratin is the major structural fibrous protein providing outer 
covering, such as hair, wool, feathers, nails, and horns of mammals, reptiles, and birds. Cysteine units are 
abundant in its chemical structure, which can be oxidized to form inter and intra molecular disulfide bonds 
leading to a strong three-dimensional polymeric network [[31]]. In contrast to chitosan, keratin is known to have 
secondary structure resulting in a denser structure compared to chitosan, therefore, keratin can make the drug 
release slower. The results obtained by Tran et al. [[33]] clearly indicate that drug release can be controlled and 
adjusted at any rate by judiciously selecting the concentration of keratin in cellulose/chitosan/keratin 
composites. Keratin has been used solely or in combination with chitosan [[34]]. When keratin is used as the 
dominant matrix [[36]] or at a high concentration, the films obtained are too fragile [[37]]. 
In this study, the combination of chitosan, gelatin and keratin was used to produce a hybrid mucoadhesive film 
for buccal delivery of hydrocortisone sodium succinate. In fact, to combine the advantages of chitosan, gelatin, 
and keratin, fabrication of composite films was examined. To the best of our knowledge, there is no report on 
the application of such a formulation for mucoadhesive drug delivery. Physicochemical, mechanical, stability, 
biodegradation, in vitro release and mucoadhesive properties of the produced composite films were also 
evaluated. 
Experimental procedures 
Materials 
Chitosan (medium molecular weight, deacetylation degree: 75–85%) and lysozyme (50000 U/mg) were obtained 
from Sigma-Aldrich. Type B gelatin (for microbiology, bloom value 90–130) and glycerol (98% reagent grade) 
were supplied by Merck Co. (Germany). Hydrocortisone sodium succinate was provided by ROTEXMEDICA 
(Germany). All other chemicals and solvents, such as acetic acid, acetone, ethylecellulose, and sodium 
hydroxide, were of analytical grade. Keratin was chemically extracted from waste wool fibers, which were 
originated from New Zealand Merino wool with a mean diameter of 21 µm. 
Films preparation 
Formulation optimization 
All films were obtained by casting the solutions of chitosan and gelatin with different ratios. First, chitosan 
(2%w/v) and gelatin (1%w/v) solutions were prepared by dissolving each polymer in acetic acid aqueous solution 
and deionized water, respectively. Also, 25 wt % (based on polymer's dry weight) of glycerol, as a plasticizer, was 
added to each solution. Then, solutions were stirred at 50 °C to achieve a homogeny mixture. To obtain 
composite films, gelatin solution was added drop-wise to the chitosan solution at different ratios according to 
Table 1, and the pH of the resulting mixture was adjusted to 5–5.5 using 1 M NaOH, then stirred for 2 h at 50 °C, 
followed by casting and evaporation. Based on the literature, a polyelectrolyte complex of chitosan and gelatin 
can only form at a pH value above the gelatin isoelectric point (i.e. 4.7) to maintain the negative net charge of 
gelatin and below the pKa of chitosan (i.e. 6.5) to prevent chitosan precipitation [[38]]. 
Table 1. Different ratios of chitosan/gelatin composite film to determine the optimized ratio. 
Sample code CH:G(w/w) 
1 1:0 
2 4:1 
3 3:1 
4 2:1 
5 1:1 
6 1:2 
7 1:3 
8 1:4 
9 0:1 
 
Keratin extraction 
Wool fibers were washed in a 60 °C solution containing 1 g/l nonionic detergent and 1%w/v sodium carbonate 
for 30 min at L:G = 40:1 ratio. Then, the fibers were rinsed several times and dried. Subsequently, Soxhlet 
extraction was carried out with petroleum ether for 12 h in order to remove the fatty matter from the fibers. 
After drying, the fibers were rinsed thoroughly with distilled water, dried and chopped into small pieces (2–
3 mm). 
In the next step, clean, defatted chopped wool fibers were immersed in a solution of Tris–HCl (pH = 8.5) 
containing 8 M urea, 0.1 M sodium dodecyl sulfate and 0.5 M sodium metabisulphite at a liquor to fiber ratio of 
20:1 for 4 h at 60–65 °C. After centrifuging and filtration, the obtained keratin solution was dialyzed against 
deionized water using cellophane tubing of 12–14 kDa molecular mass cutoff for 3 days with frequent water 
changes, and finally, it was freeze dried for 48 h to prepare the keratin powder [[40]]. It is worth mentioning that 
Cilurzo et al ascertained that the extracted keratin did not induce any appreciable cytotoxicity at any of the 
concentrations or time-points tested [[41]]. 
Preparation of drug loaded chitosan/gelatin/keratin composite 
After optimizing the chitosan/gelatin ratio, keratin was added at different ratios to the complex. Thus, 0.5, 1, 
and 1.5% (W/V) of keratin powder was added to the gelatin solution and stirred (300 rpm) for 30 min to obtain a 
homogeneous solution. The samples were labeled CHGK1, CHGK2 and CHGK3, respectively. 100 mg of the drug 
was then added to the obtained solution and stirred (300 rpm) for 15 more minutes. The prepared solution was 
transferred to the separatory funnel and added to the chitosan solution drop-wise for composite film 
preparation as described previously. 
Preparation of the second layer 
Ethylcellulose was used as a backing layer to control the release rate of the samples. To prepare the second 
layer, ethyl cellulose was dissolved in acetone (5%w/v) first. To enhance the mechanical properties of the film, 
glycerol was added to the solution (25%w/w of the dried weight of ethyl cellulose), and stirred at 300 rpm for 
2 h. In fact, the incorporation of glycerol into polymer films eliminates their fragility and improves their 
flexibility. Then, a certain volume of the solution equal to the first layer was poured on glass petri dish and 
allowed to dry at room temperature. 
Film characterization 
Compositional characterization 
FTIR spectra of the films were collected using a Nicolet Nexus 670 after preparation of KBr pellets. The FTIR 
spectra were recorded in a wavenumber range of 4000 to 400 cm−1 at a resolution of 4 cm−1. 
Morphological observations 
Microstructure and morphology of the prepared films was examined by scanning electron microscopy (SEM; 
Philips XL30). The imaging was carried out at the acceleration voltage of 20 kV after gold (Au) coating. 
Mechanical properties 
To investigate the mechanical properties, the films were cut to the pieces of 2.5 cm × 10 cm. Mechanical 
properties measurements were carried out using a universal testing machine (Instron 5566) at a cross speed of 
25 mm/min, according to ASTM D882–02. The thickness of each sample was measured by a thickness gauge 
(SDL), and the cross sectional area was calculated. The tensile strength and elongation at break were 
determined by the following formulas [[42]]. The values were expressed as mean ± standard error (n = 5). 
( 1) Tensile strength (MPa) = Force at break (N)Cross sectional area (mm2) × 100 
 ( 2) Elongation at break (%) Increas in lenght (mm)Original lenght (mm) × 100 
 
Swelling/water uptake capacity 
Films were cut into 1 cm × 1 cm pieces and weighed to obtain the dry weight. Samples were then immersed in 
10 ml artificial saliva (KinHydrate, pH = 6.8) and incubated at 37 °C. After 24 h of immersion, the samples were 
weighed subsequent to removing the water on the surface by filter paper. Then, the samples were transferred 
to an oven, kept at 60 °C for 4 h and desiccated for 48 h. The percentage of water uptake (swelling) and matrix 
erosion or dissolution (%DS) were calculated using the following equations: 
( 3) %SW  or  𝑊𝑊uptake =  𝑊𝑊𝑤𝑤 −𝑊𝑊𝑑𝑑𝑊𝑊𝑑𝑑 × 100 
( 4) %DS =  𝑊𝑊𝑑𝑑 −𝑊𝑊′𝑑𝑑
𝑊𝑊𝑑𝑑
× 100 
Where Wd and Ww are dry and wet weight of the samples, respectively. W'dis the weight of the samples after 
drying in the oven [[43]]. The values were expressed as mean ± standard error (n = 5). 
Moisture content and total soluble matter 
The samples were weighed (W0) and subsequently dried in an oven at 100 °C for 24 h. Films were then 
reweighed (Wd), to measure their moisture content (MC): 
( 5) %MC =  𝑊𝑊0 −𝑊𝑊𝑑𝑑
𝑊𝑊0
× 100 
Total soluble matter (TSM) was determined by immersing the dried samples in 10 ml of distilled water at 
ambient temperature for 24 h. Subsequently, the samples were dried again at 100 °C for 24 h to find the weight 
of dry matter insoluble in water. TSM was calculated using the following equation: 
( 6) %TSM =  𝑊𝑊1 −𝑊𝑊2
𝑊𝑊1
× 100 
where W1 is the initial dry matter and W2 is the undissolved dry matter after immersion. 
Stability in PBS and biodegradation in lysozyme 
The samples were weighted in the dry state (W1). Then, they were immersed in the phosphate buffered saline 
(PBS) (pH = 7) with (for biodegradation assay) and without (for stability assay) 104 U/ml lysozyme for 1–7 days at 
37 °C.The samples were weighed again after removing the water on the surface by filter paper (Wt). The 
percentage of stability (%ST) and biodegradation (%BD) were calculated by the following formulations: 
( 7) %ST =  𝑊𝑊𝑡𝑡
𝑊𝑊1
× 100 
( 8) %BD =  𝑊𝑊1 −𝑊𝑊𝑡𝑡
𝑊𝑊1
× 100 
It is worth mentioning that after each measurement, the solution was replaced with the fresh media to retain 
consistency in the pH and enzyme activity [[44]]. The values were presented as mean ± standard error (n = 5). 
Surface pH of films 
Surface pH was measured to evaluate the possible damage to mucus by the films. Samples were immersed in 
artificial saliva (pH = 6.8) for 2 h. Samples were taken out and the pH of each film was recorded by placing the 
probe of pH meter in contact with the wet sample [[14]]. The values were expressed as mean ± standard error 
(n = 5). 
MTT assay 
The cell proliferation on the prepared films was determined according to ISO 10993–5 using MTT (3–(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The prepared films were first disinfected by 
immersion in 70% v/v ethanol solution for 30 min and were subsequently kept under UV for 1 h. The samples 
were then dried in a vacuum oven and washed with sterile PBS at least five times prior to use. To produce the 
extracts for each film, the samples were incubated in 1 ml of RPMI 1640 culture medium (Sigma) supplemented 
with 10% (w/w) fetal bovine serum (FBS, GIBCO) while shaking for 3 and 7 days. Culture medium (RPMI and FBS) 
kept under the same condition was employed as the negative control. 
To conduct MTT assay, L929 fibroblast cells were seeded into 96-well plates at a density of 1 × 104 cells/well and 
cultured under standard aseptic conditions. Then, the culture medium in each well was replaced with 90 µL of 
extraction media together with 10 µL FBS and was incubated for another 24 h. Then, 10 µL of a 0.5 mg/mL MTT 
solution was added to each well followed by incubation for 4 h at 37 °C. Formed formazan crystals were 
dissolved by the addition of 100 µL of isopropanol (Sigma) to each well. Subsequently, after 15 min of slow 
shaking, the optical density was recorded using a multiwell microplate ELISA reader at a wavelength of 545 nm. 
Finally, the obtained data was normalized with regard to the negative control. 
In vitro release of hydrocortisone sodium succinate from buccal patch 
The drug release rate from the mucoadhesive film was investigated through immersing samples in 10 ml of PBS 
(pH = 7.4) at 37 ˚C. The drug release was evaluated by a UV spectrophotometer (SHIMADZU, UV-160) at a 
wavelength of 247 nm and at time intervals of 1, 2, 3, 4, 5, 6 and 24 h. (101 103 104,105,108). The values were 
expressed as mean ± standard error (n = 3). 
Mucoadhesive force and residence time 
The required tensile load to separate the mucoadhesive patch from the mucus membrane is one of the criteria 
for mucoadhesive performance [[46]]. Mucoahesive force measurement was performed on a sheep buccal 
mucus membrane as a model membrane. The mucus membrane was separated from underlying connective 
tissue and washed thoroughly by PBS (pH = 7.4). The apparatus was made in Shahid Beheshti University of 
Medical Sciences, School of Pharmacy in Tehran, Iran [[47]]. The mucus membrane was fixed on a circular 
surface with a diameter of 15 mm. The other surface with the same diameter was attached to a balance using a 
string. Films, with a diameter of 15 mm, were attached to the upper disk and they pressed onto the mucus 
membrane manually for 120 s, and then, pulled with a constant speed of 0.5 mm/s. The detachment force was 
considered as the mucoadhesion force. 
The detachment time was also considered as the mucoadhesion residence time [[43], [46]]. The values were 
expressed as mean ± standard error (n = 5). 
Statistical analysis 
Statistical analysis was carried out using SPSS software. One-way analysis of variance (ANOVA) and Tukey's test 
were performed to determine statistically significant differences between the experimental groups. p < .05 was 
considered as statistical significance. Error bars indicate the standard deviation from the mean value. 
Results and discussion 
SEM observations of chitosan, gelatin, and gelatin/chitosan composite films 
The micrographs of chitosan, gelatin, and gelatin/chitosan composite films are shown in Figure 1. As it can be 
observed in this figure, the composite films display homogeneous surfaces with superb structural unity. Also, 
gelatin/chitosan composite films exhibit a compact, uniform, dense, and homogenous appearance. It is 
noticeable that no interfaces are seen in the blend, ascertaining a high compatibility between components due 
to associative interactions to form polyelectrolyte complex (PEC). 
 
Figure 1. SEM micrographs (cross section view) of (A) chitosan, (B) gelatin, and (C) chitosan/gelatin (3:1) composite films. 
Formulation optimization 
Mechanical properties 
Mechanical properties of different samples are presented in Figure 2. In order to compare samples, the data 
values are shown in column charts of tensile strength and elongation at break. 
 
Figure 2. (A) Tensile strength and (B) Elongation at break of the film with different ratios of chitosan/gelatin. 
The mechanical evaluation of films is of great importance for its application in the buccal cavity. Chitosan is rigid, 
and it is expected that the flexibility of the films would increase by adding gelatin [[38]]. 
It is reported that the mechanical properties of chitosan films, or composites containing chitosan, are dependent 
on the molecular weight of polymer, pH of the film forming solution and its degree of deacetylation. Moreover, 
the type of acid to dissolve chitosan, drying condition and the amount of water in the film affect these 
properties [[48]]. 
Electrostatic interactions and hydrogen bonds between chitosan, which is an amino polysaccharide, and gelatin 
are effective on the tensile strength and elongation at break [[54]]. In Figure 2, it is observed that the tensile 
strength (TS) of gelatin increases as a result of the addition of chitosan due to its rigidity. Strong interaction 
between gelatin and chitosan is a reason for this behavior [[55]]. The backbone of gelatin contains free 
negatively charged carboxyl groups, enabling it to blend with the cationic ammonium groups of chitosan to form 
a network. Also, composite films have lower TS compared to chitosan film, which is attributed to the reduction 
of chitosan crystallinity by the presence of gelatin [[39]]. Sample 3 (CH:G = 3:1) exhibits an average TS of 
92.78 MPa which is statistically higher than the other samples (p < .05), and therefore, it was chosen as an 
optimal sample. It shows that the best compatibility of chitosan and gelatin occurs at this ratio, which 
corresponds well with other reported literature [[56]]. 
Moisture content and solubility 
Moisture content is a factor attributed to the total void volume occupied by water molecules in the network 
microstructure of the film, whereas solubility is attributed to the hydrophilicity/hydrophobicity of the material. 
According to the results given in Table 2, gelatin film displays the highest moisture content. TSM value is a 
parameter of the resistance of films against water. Gelatin films are completely soluble in water. It is important 
to point out that composite films are notably less soluble than gelatin, which could arise from interactions, such 
as electrostatic forces between positively charged chitosan and negatively charged gelatin at the operating pH 
(5.5). 
Table 2. Moisture content and total soluble matter of different films. 
Sample code Moisture content (%) Total soluble matter (%) 
1 10.75 ± 0.6 10.42 ± 0.7 
2 12.59 ± 0.6 16.25 ± 0.6 
3 12.78 ± 0.4 16.40 ± 0.5 
4 12.77 ± 0.6 17.57 ± 0.5 
5 11.56 ± 0.5 17.92 ± 0.6 
6 6.44 ± 0.4 21.43 ± 0.5 
7 11.38 ± 0.3 22.29 ± 0.7 
8 11.54 ± 0.6 29.38 ± 1.4 
9 12.67 ± 0.5 100.00 ± 0.0 
 
Stability and biodegradation properties 
The results of the stability test in PBS (pH = 7.4) at 37 °C and biodegradation test in PBS (pH = 7.4) in the 
presence of lysozyme at 37 °C are displayed in Figure 3. It should be noted that gelatin film nearly dissolves 
within a few hours; therefore, this film is not tested later on. As can be observed, stability of the films decreases 
in the first 4 days, and then, it reaches a plateau and the films reach a constant stability and display a rational 
trend. One of the possible explanations of this observation lies in the high solubility of the gelatin in aqueous 
environment. This leads to lower stability of gelatin film in comparison with the films containing chitosan. Also, 
by increasing chitosan in formulations, the stability increases and the complex has higher stability than gelatin 
films. Composite films are much more stable than gelatin film due to the formation of a polyelectrolyte complex, 
but they show lower stability compared to the chitosan film because of the high solubility of gelatin in an 
aqueous environment. 
 
Figure 3. (A) Stability of the films in PBS and (B) Biodegradation of the films in PBS with lysozyme at 37 °C in the period of 1–
7 days. 
Since lysozyme is one of the most abundant enzymes in human body, especially in the oral cavity, the 
degradation of films by this enzyme is substantial. Figure 3(B) shows that samples with a higher amount of 
gelatin have a higher amount of biodegradation, owing to severe hydrolysis of gelatin macromolecules as a 
hydrophilic polymer [[59]]. 
The β-1,4 N-acetyl-glucose amino groups of chitosan chains can be hydrolyzed by lysozyme, leading to the 
release of amino sugars that can either enter the metabolic pathway of glycosaminoglycan and glycoprotein or 
be excreted. Furthermore, the hydrophilic nature of chitosan allows for water penetration in the matrix more 
rapidly than the rate of degradation, and so, chitosan swells before degradation [[58]]. 
The degradation rate is high in the first 4 days and is reduced in the following days. It seems that fast weight 
reduction at the beginning is related to gelatin hydrolysis, and slow weight loss in the following days is due to 
chitosan degradation by the lysozyme [[61]]. 
Films containing drug and keratin 
SEM observations of chitosan/gelatin composite containing keratin 
SEM micrographs of chitosan/gelatin composite film containing keratin are shown in Figure 4. As it can be 
observed, keratin is rather uniformly distributed throughout the composite film. Meanwhile, some aggregates of 
the keratin are seen in the composite film. The addition of keratin leads to a more compact, aggregated and 
irregular structure than the chitosan/gelatin composite film in Figure 1(C). 
 
Figure 4. SEM micrographs (cross section view) of chitosan/gelatin (3:1) composite film containing keratin. 
FTIR analysis 
To evaluate the structure of a drug and its presence in the films, FTIR spectra of drug as well as chitosan/gelatin 
composite containing a drug and keratin are presented in Figure 5. 
 
Figure 5. FTIR spectra of (A) drug powder and chitosan/gelatin composite containing drug and (B) Chitosan/gelatin 
containing drug and chitosan/gelatin/keratin (1.5 W/W %) containing drug. 
The characteristic peaks of chitosan, gelatin and their complex were depicted completely in previous articles 
[[39]]. The spectrum of the drug exhibits a broad absorption band at 3435 cm−1 which results from 0-H stretching 
vibrations. The peak of 2931 cm−1 is assigned to stretching vibrations of aliphatic C-H. The sharp peak at 
1720 cm−1 is assigned to the ketone group and the 1655 cm−1 absorption band corresponds to a carboxylate 
group in the drug structure. Also, 1057 cm−1 is a characteristic peak of a C-O-C stretching band [[62]]. 
In composites, the characterization peaks of the drug can be seen with slight differences. The peak situated 
around 3376 cm−1 is related to the overlapping of O–H and N–H. The spectra of the composite containing the 
drug exhibit a shorter peak at 3418 cm−1. This shift may be related to hydrogen bond of O–H and N–H group 
existing in the drug and composite structure. Besides, the presence of a drug in the composite structure results 
in the shift of the drug's absorption bands from 1655 and 1720 cm−1, respectively, to 1645 and 1711 cm−1. It 
seems that ketone and carboxylate groups, which are deactivator groups, absorb electrons on the drug structure 
and are able to attract hydrogen that is abundant in the composite. 
Characterization peaks of a composite containing keratin powder are approximately identical to a composite 
without keratin. Thus, by adding keratin to the matrix, no basic alteration occurs to the composite structure. The 
slight variations in saccharide and amide regions are due to the presence of keratin in the composite system. For 
example, stretching vibrations of C–O at 1080 and 1152 cm−1 in three component systems increases in 
comparison with chitosan/gelatin composite. 
Observations indicate that the presence of a drug has no significant effect on complex structure. Furthermore, 
keratin does not cause any chemical degradation to the structure, but it cooperates in the bonds existing within 
structure. 
Mechanical properties 
Mechanical properties of the samples are shown in Figure 6(A) tensile strength and (B) elongation at beak. Some 
authors believe that the addition of keratin to chitosan results in increased flexibility and elongation at break. 
However, the opposite trend was reported for tensile strength [[34]]. Besides, the existence of chitosan, gelatin 
and keratin represents more acceptable properties compared to chitosan/gelatin and chitosan/keratin 
composite or even keratin film [[64]]. For keratin film, a tensile strength of about 0.25 has been reported that is 
about 0.2 of the tensile strength that was obtained in this project [[19]]. 
 
Figure 6. (A) Tensile strength and (B) Elongation at break for the different films. 
By comparison of chitosan/gelatin (3:1) composite films with and without a drug, it can be concluded that the 
tensile strength and elongation at beak were reduced in the composites containing a drug due to the 
disintegration of composite matrix. On the other hand, by adding keratin to the composite formulation, the 
interactions between the drug and composite improve, and therefore, tensile strength, and elongation at break 
increase by increasing keratin percentage. This result affirms the influence of keratin in composites. Judging 
from the reports, a composite film containing 1.5% keratin represents the most desirable mechanical properties. 
Swelling, water uptake and erosion percentage 
As it is shown in Figure 7, samples containing 1% keratin absorbs more water in artificial saliva compared with 
the other samples. 
 
Figure 7. Water uptake of the films after different times ( 1, 2, 3, 4, 5 and 6 h) immersion in artificial saliva. 
Similar to the mechanical test results, CHGK1 that has 0.5% keratin has identical behavior to CHG (0% keratin). It 
seems that a small concentration of keratin has no effect on the final properties of the film. In CHGK2 and 
CHGK3, the water uptake percentage is more than the other two samples. The isoelectric point (PI) of keratin is 
about 4.9. Thus, at pH = 6.8 this polymer is negatively charged. Keratin molecules with a negative charge repel 
each other, and this repulsion causes water to penetrate inside the polymer matrix and induce swelling [[31], 
[64]]. On the other hand, by increasing keratin from 1 to 1.5%, swelling decreases. The reason for this happening 
may be the presence of keratin molecules amongst chitosan chains. Hence, keratin molecules separate chitosan 
chains to prevent amine group repulsion [[34]]. This phenomenon is an affirmation of previous tests, which 
explained that at a higher percentage of keratin, more proper interaction occurs between the keratin and 
chitosan/gelatin complex. 
Water uptake percentage was also measured after 24 h (for film saturation). The results are shown in Figure 8. 
The same trend is observed in this figure. 
 
Figure 8. Water uptake percentage of the films after 24 h immersion in artificial saliva. 
The sample's erosion is calculated after 24 h and depicted in Figure 9. For all samples, a positive digit was the 
result because of the low thickness of the films. Due to low thickness of films, fragmentation may happen. 
Approximately all samples were affected by this phenomenon. The greatest weight reduction occurs in CHGK2 
(1%). This may be because of a higher degree of swelling in this film compared to others. High swelling causes 
vacancies in the film's matrix and makes the film more brittle against mechanical stress. 
 
Figure 9. Erosion or dissolution [DS (%)] of the films after 24 h immersion in artificial saliva. 
Stability in PBS and biodegradation in lysozyme 
Stability was carried out in the period of 1–7 days and 0–6 h at 37˚C in PBS at pH = 7.4. As it is depicted in Figure 
10, throughout the first few hours, the stability of the film containing 1% keratin is higher. This is related to the 
higher swelling ratio of this film compared to the other films. However, after 4 h, CHGK3 (1.5% keratin) shows 
more stability. 
 
Figure 10. Stability of the different films in PBS at pH =7.4 for (A) 0–6 h and (B) 1–7 days. 
It is obvious that even after 24 h, CHGK3 (1.5%) is the most stable film due to its logical swelling in comparison 
with the other samples. This logical swelling prevents the film from experiencing fragmentation, and the film 
preserves its structure. 
The biodegradation of samples in PBS (pH = 7.4) in the presence of 104 U/ml lysozyme is depicted in Figure 11. 
The film containing 1.5% keratin has the least degradation in the first 6 h. It seems that an interaction between 
keratin macromolecules and chitosan/gelatin composite, like hydrogen bonds, prevents enzyme penetration and 
film degradation. As a matter of fact, these particles are applied as barriers against enzymatic hydrolysis. It is 
impressive that even CHGK1 (0.5%), the film with the least amount of keratin, has less degradation than the 
chitosan/gelatin composite (CHG). Therefore, keratin enhances the film resistance to enzymatic degradation. 
 
Figure 11. Biodegradation rate of the chitosan/gelatin composite film containing different ratios of keratin in PBS at pH =7.4 
in the presence of 104 U/ml lysozyme in a period of (A) 0–6 h and (B) 1–7 days. 
Even after passing days, the trend of degradation (Figure 11(B)) is identical to the first diagram (Figure 11(A)). It 
is obvious that the film containing 1.5% keratin shows the least biodegradation ratio. 
Surface pH of samples 
As it is shown in Table 3, all pHs are about 6.3–6.5, proving that films didn't change the pH of the environment 
to acidic or basic nature. Thus, no harmful effect to mucus is expected [[14], [66]]. 
Table 3. Surface pH of chitosan/gelatin composite film containing different ratios of keratin. 
Surface pH Sample code 
6.35 ± 0.0702 CHG 
6.46 ± 0.2011 CHGK1 
6.38 ± 0.1041 CHGK2 
6.36 ± 0.0929 CHGK3 
 
MTT assay 
The results obtained by MTT assay for different films were compared with the control group (polystyrene well) 
as shown in Figure 12. 
 
Figure 12. Cell proliferation of fibroblast cells proliferated on the different films along with negative control after incubation 
for 5 and 10 days. 
According to the results, the cell viability on the gelatin film is similar to the control group. Gelatin is constituent 
of some amino acids, such as arginine, glycin and aspartic acid (RGD sequence), that stimulate cell adhesion and 
migration. Also, nonspecific cell interaction occurs between chitosan positively charged ammonium sites at 
physiological pH and negatively charged cell membrane surfaces. Therefore, the gelatin/chitosan composite film 
appears to be favorable for cell adhesion, and the biological activity of chitosan is enhanced upon blending with 
gelatin. 
It is worth mentioning that no statistical difference in cell viability is detected between the chitosan/gelatin 
composite film and the other films, but the number of cells decreases significantly (p < .05) in chitosan/gelatin 
composite film containing keratin in comparison with chitosan/gelatin composite film, which could be due to the 
reduction in the hydrophilicity. Meanwhile, the slightly higher number of cells on the surface of the films after 
10 days ascertains their good affinity and biocompatibility for cells. 
In vitro drug release 
As it is depicted in Figure 13, the drug release profile in all samples is linear. Thus, the mechanism of drug 
release is diffusion [[67]]. 
 
Figure 13. Drug release profile in the chitosan/gelatin composite film containing different ratios of keratin over 120 h. 
To discuss the results of drug release thoroughly, the profile of release in the first 20 h is described below (see 
Figure 14). In the first 3–4 h, burst effect occurs, which releases about 80% of the drug concentration. Thus, 
there is only little amount of the trapped and remaining drug in all films. The degree of drug release from CHGK2 
is the highest among samples. Due to the predominant diffusion mechanism of drug release in this system, 
excessive diffusion of water in CHGK2 (1%) leads to the dissolution of the drug and sudden release of 
hydrocortisone sodium succinate. After initial burst release, owing to the sudden decrease in drug 
concentration, the entanglement of polymer chains decreases, which results in greater release in the following 
hours due to the generation of vacancies [[14]]. 
 
Figure 14. Drug release profile in the chitosan/gelatin composite film containing different ratios of keratin in the first 20 h. 
On the other hand, CHGK3 (1.5%) has the smallest slope in the graph, which indicates slower drug release. In the 
CHGK3 film, the final release is lower than the other films. It appears that by increasing the keratin ratio, the 
interaction between drug and keratin particles increases, which results in drug entrapment in the system. In the 
film containing 1.5% keratin, lower pore formation and less erosion contributes to slower drug release [[68]]. 
In comparison with previous research studies, the presence of a backing layer in the system increases the 
release time remarkably. For example, Abruzzo et al. reported a release period of about 30 min for their 
chitosan/gelatin system [[19]]. This backing layer causes unilateral release and prevents excessive swelling. 
In some research about release kinetics, burst release is a phenomenon generally seen in delivery devices of 
different types, form and compositions. The burst effect might be suitable for specific applications such as 
targeted delivery, encapsulated flavors, wound treatment and pulsatile release. Notwithstanding, it is also likely 
to cause negative impacts such as short in vivo half-life, local/systemic toxicity and shortened release profile that 
requires more periodic dosing [[69]]. Burst release is frequently associated with surface properties of host 
material, heterogeneous distribution of drugs within the polymer matrix, device geometry and intrinsic 
dissolution rate of drug, heterogeneity of matrices (pore density). However, some works have been carried out 
to develop mechanism based mathematical models for burst release. It is noticeable that for better predicting 
and understanding the burst release, it would be useful to develop models to clarify the mechanisms of burst 
release [[70]]. 
Surface degradation and bulk degradations are two general types of degradation. In a surface-degrading 
polymer, degradation is limited to the external surface of the device [[71]]. In a bulk-degrading polymer, 
degradation happens homogeneously throughout the material [[72]]. Water is a crucial factor amid hydrolysis 
and therefore water intrusion into the device is of remarkable significance for the research of degradation 
kinetics as well as release kinetics. The degradation of semicrystalline polymers occurs in two steps: 
• The first step comprises of water infusion into the amorphous areas with random hydrolytic scission of 
labile bonds, such as ester bonds 
• The second step initiates when most of the amorphous areas are degraded. As degradation results in 
the scission of polymer chain, the change in the average molecular weight of the polymer could be 
utilized to quantify the degradation process over time. Employing gel permeation chromatography 
(GPC), the degradation process is generally examined by plotting the average molecular weight of the 
degraded biomaterial vs time. The following two equations are broadly employed to explain the 
degradation kinetics: 
• ( 1) Zero − order ∶  Mw(t)  =  Mw0kdegt 
• ( 2) Pseudo − first order ∶  Mw(t) = Mw0eexp(−kdegt) 
where Mw(t) and Mw0 are the average polymer molecular weight at time tand zero. kdegr is related to the 
apparent degradation rate constant of the polymer [[70]]. 
Mucoadhesive force 
When a mucoadhesive patch fabrication is claimed, its adhesion to mucus for a distinctive period of time should 
be guaranteed. Figure 15 shows the column graph of the mucoadhesive force of the films. Although hydrophilic 
molecules, like chitosan, shows mucoadhesive properties, excessive swelling of these molecules can form a 
loose, slippery layer on the mucus, which limits its application. However, by adding a polymer with the opposite 
charge to cationic chitosan and the formation of a three dimensional network, swelling can be controlled [[68]]. 
Previous studies expressed that the addition of a high amount of gelatin also reduces the mucoadhesion force of 
chitosan/gelatin composite due to its high swelling ratio. Thus, the chitosan/gelatin ratio should be optimized in 
the composite to achieve the best results. Furthermore, it was mentioned that high proportions of cationic 
chitosan chains could react with sialic acid and sulfate parts of mucus glycoproteins, which have a negative 
charge in the oral cavity [[19]]. Thus, the mucoadhesive force in chitosan/gelatin film is the result of this 
reaction. 
 
Figure 15. Mucoadhesive force of the chitosan/gelatin composite film containing different ratio of keratin. 
It should be stated that the bridge structure (disulfide bonds) in biological systems is of great importance for 
binding films to the mucus surface. Thiol polymers, or thiomers, are basically mucoadhesive and have thiol 
groups in their side chains. By thiol/disulfide exchange* reactions or a simple oxidation, disulfide bonds can be 
formed between these polymers and subdomains that are rich in cysteine*. Thus, thiomers mimic the natural 
mechanism of secreted mucus by forming covalent disulfide bonds [[73]]. In fact, mucus structure can be 
summarized to repetitive arrays, carboxylic regions and amino ends. More than 10% of carboxylic ends are 
cysteines. Also, amino ends have regions rich in cysteine, which are responsible for forming mucin oligomers in 
disulfide bonds. 
Based on disulfide exchange, disulfide bonds form between mucin glycoproteins and mucoadhesive thiol 
polymers, which leads to covalent interaction [[ 6]]. 
As demonstrated in Figure 15, with increasing keratin content, the mucoadhesion force increases. The film 
containing 1.5% keratin displays the highest mucoadhesion force. It seems that, besides the interaction of the 
polyelectrolyte complex and mucus, keratin molecules, with cyteine regions, can form bonds with glycoproteins 
and develop the mucoadhesion of the composite. 
Mucoadhesion residence time 
Different parameters affect the mucoadhesion time. One of them is the ability of polymers to absorb water. A 
polymer that can maintain its structure against water can adhere longer on mucus. Another significant factor is 
the type of film-forming polymer and polymer blend uniformity. Some researchers believe that physical and 
chemical properties of the polymer have a substantial effect on polymer residence time on mucus while others 
argue that there is no relation between mucoadhesive residence time and mucoadhesive force, and highly 
adherent polymers do not necessarily adhere on mucus for a long time [[43]]. They believe that surface charge 
density and flexibility of the chain are the major factors leading to high adhesion strength. Residence time also 
depends on the solubility rate of the applied polymers, and the presence of a hydrophobic polymer in the blend 
lengthens the mucoadhesion residence time [[46], [74]]. 
Figure 16 represents residence time of chitosan/gelatin composite containing different ratios of keratin. CHGK3 
(1.5%) has the longest residence time on mucus amongst all samples. On the other hand, the chitosan/gelatin 
composite without keratin shows the shortest residence time. Based on the results of the swelling test, keratin 
decreases the swelling rate in the chitosan/gelatin composite, and a balanced swelling ratio leads to increased 
adherence of polymer to mucus. 
 
Figure 16. Mucoadhesive residence time for chitosan/gelatin composite film containing different ratios of keratin. 
Amongst the three films containing keratin, CHGK2 (1%) has the shortest residence time on mucus because of its 
excessive swelling. On the other hand, the film containing 0.5% keratin (CHGK1) adheres for a longer time in 
comparison with CHGK2 (1%) due to its better stability in PBS, as it was previously shown. 
Conclusions 
A chitosan/gelatin film was formed by casting in different ratios. To optimize the best proportion of the 
components, different characteristics, such as tensile, swelling, stability and biodegradation, in lysozyme were 
tested. It was found that the chitosan/gelatin composite film with the ratio of 3:1 was chosen as the optimum 
sample for fabricating the mucoadhesive patch. Keratin, which was extracted chemically from wool, was 
incorporated in the chitosan/gelatin composite in three different ratios together with hydrocortisone sodium 
succinate as an anti-inflammatory drug for the treatment of desquamative gingivitis. FTIR spectra confirmed the 
presence of the drug and keratin in the system without any destruction in composite structure, and the 
existence of some specific interactions between them was also noted. The tensile strength, as well as elongation 
at break, also increased by increasing keratin extent. The film containing 1.5% keratin was recognized as the 
most stable sample in PBS after 24 h due to its low water absorption. In addition, keratin acted as a barrier to 
enzyme diffusion to composite structure and enzymatic hydrolysis because of the formation of hydrogen bonds. 
Thus, with an increase in the amount of keratin, the biodegradation rate decreased. By evaluating the surface 
pH of samples, it was concluded that these films cannot damage mucus surface. The release profile 
demonstrated that keratin acts as a rate controller in the system. Based on the interactions between keratin and 
drug particles, some drugs were trapped in the system even after 120 h. The results of the mucoadhesion test 
demonstrated that higher concentrations of keratin results in a higher mucoadhesive strength that is related to 
the formation of disulfide bonds between keratin and mucus glycoproteins. Moreover, the presence of keratin 
increased the mucoadhesion time. Eventually, chitosan/gelatin (3:1) composite containing 1.5% keratin 
displayed the best result for the treatment of desquamative gingivitis with hydrocortisone sodium succinate. 
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